Doctorate at Sinai University, Egypt
Professional Profiles
Google Scholar
Scopus
Orcid
🎓Educational Background
Dr. Amira Abdel Halim Hamada Boseila has a rich academic background in pharmaceutical sciences. She earned her Doctor of Philosophy (PhD) in Pharmaceutical Sciences from the Faculty of Pharmacy, Cairo University in February 2020. Her PhD thesis focused on “Utility of nanocarriers for targeted delivery of an antiviral drug to the liver.” Prior to that, she obtained her Master’s in Pharmaceutical Sciences from the same institution in December 2013, with her thesis titled “Formulation and Evaluation of Modified Nasal Drug Delivery System of an Antiemetic Drug: Ondansetron.” Additionally, Dr. Boseila completed a Total Quality Management Diploma (TQM) from the American University of Cairo in 2009, further strengthening her expertise in quality control management. She began her academic journey with a Bachelor of Pharmaceutical Sciences from Cairo University in May 2007, graduating with a “very good” grade. Her early education was at La Rose De Lisieux Language School, Dokkie, where she specialized in science.
🔬Research Interests
Dr. Boseila’s research interests span across several cutting-edge areas within pharmaceutical sciences. Her focus includes nanomedicine, drug targeting, modified release dosage forms, novel drug delivery systems, and quality by design. These interests guide her contributions to the field, particularly in exploring innovative approaches to drug formulation and delivery.
💼Career History and Professional Experience
Dr. Boseila is currently a Full-time Lecturer of Pharmaceutical Sciences at the Faculty of Pharmacy, Sinai University, where she has been since September 2022. In this role, she teaches various PharmD courses such as “Advanced Drug Delivery Systems,” “Design of Dosage Forms,” and several key subjects in pharmaceutics and pharmaceutical technology. Before this full-time position, she was a Part-time Lecturer at Sinai University, delivering lectures on Industrial Pharmacy and Hospital Pharmacy from February to June 2022.
In parallel, Dr. Boseila has served as a Post-doctoral Researcher at the Department of Pharmaceutics, Egyptian Drug Authority in Giza, Egypt, since July 2020. She has also been an Associate Researcher of Pharmaceutics and Lead Quality Control Specialist at the National Organization for Drug Control and Research (NODCAR) between January 2018 and March 2020. In her professional roles, Dr. Boseila has held key management positions, including Head of the Comparative Dissolution Unit at the Egyptian Drug Authority and Technical Manager of the Physicochemical Lab.
Additionally, she has contributed as a Guest Lecturer for the “Drug Targeting” course at the Applied Biotechnology Department, Faculty of Science, Ain Shams University, a position she has held since October 2020.
🧪Projects and Research Contributions
Dr. Boseila has actively participated in several significant research projects. In June 2023, she led a project titled “Repurposing of Anti-inflammatory Active for the Treatment of Inflammatory Pulmonary Diseases,” funded by the University of Hail. This project, with a 12-month duration, focuses on innovative treatments for pulmonary conditions. Another notable project she spearheaded was the development of a “Nano Phyto-throat spray,” aimed at providing an effective post-exposure prophylaxis and treatment strategy for COVID-19. This project, funded by the Misr El Kheir Foundation, ran from October 2021 for 12 months.
Publications Top Noted📚
Throat Spray Formulated with Virucidal Pharmaceutical Excipients
Authors: Boseila, A.A., Ghareeb, A.Z., AbdElwahab, M.G., Yassa, N.W., Ghareeb, D.A.
Journal: European Journal of Pharmaceutics and Biopharmaceutics
Year: 2024
Antidepressant and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum perforatum on Post-Myocardial Infarction Depression in Rats
Authors: Khalil, H.M.A., Mahmoud, D.B., El-Shiekh, R.A., Naggar, R.A., Eliwa, H.A.
Journal: AAPS PharmSciTech
Year: 2022
Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
Authors: Damiri, F., Andra, S., Kommineni, N., Berrada, M., Cavalu, S.
Journal: Materials
Year: 2022
Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the “Era of the-Green”: A Systematic Review
Authors: Hamdy, N.M., Boseila, A.A., Ramadan, A., Basalious, E.B.
Journal: Pharmaceutics
Year: 2022
In Silico and in Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
Authors: Elmaaty, A.A., Darwish, K.M., Chrouda, A., Mustafa, M., Al-Karmalawy, A.A.
Journal: ACS Omega
Year: 2022
Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
Authors: Boseila, A.A., Rashed, H.M., Sakr, T.M., Abdel-Reheem, A.Y., Basalious, E.B.
Journal: Molecular Pharmaceutics
Year: 2019